Pfizer Inc. has chosen Source/Chinnici to be the agency of record for its Xalatan product. Xalatan is a prescription medicine used to reduce eye pressure and risks from Glaucoma. The value of the contract was not disclosed.
Advertisement
Pfizer Inc. has chosen Source/Chinnici to be the agency of record for its Xalatan product. Xalatan is a prescription medicine used to reduce eye pressure and risks from Glaucoma. The value of the contract was not disclosed.
Source/Chinnici is a joint venture between Source Marketing of Westport, NY and Chinnici Direct Inc. of Manhattan. Both agencies are partner firms of Toronto-based MDC Partners.
Source/Chinnici’s responsibilities will include acquisition, customer relationship marketing and brand duties.
